Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

Nonfiction, Health & Well Being, Medical, Specialties, Toxicology, Medical Science, Pharmacology
Cover of the book Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780123948236
Publisher: Elsevier Science Publication: June 27, 2013
Imprint: Academic Press Language: English
Author:
ISBN: 9780123948236
Publisher: Elsevier Science
Publication: June 27, 2013
Imprint: Academic Press
Language: English

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

  • Provides in-depth coverage of the process of nonclinical safety assessment and comprehensive reviews of each type of biopharmaceutical
  • Contains the most pertinent international regulatory guidance documents for nonclinical evaluation
  • Covers early de-risking strategies and designs of safety assessment programs for novel biopharmaceuticals and vaccines, as well as follow-on biologics or "biosimilars"
  • A multi-authored book with chapters written by qualified experts in their respective fields
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

More books from Elsevier Science

Cover of the book Handbook on the Physics and Chemistry of Rare Earths by
Cover of the book Underbalanced Drilling: Limits and Extremes by
Cover of the book Mechatronics '98 by
Cover of the book Fundamentals of Osteoporosis by
Cover of the book Annual Reports on NMR Spectroscopy by
Cover of the book Practical Leadership for Biopharmaceutical Executives by
Cover of the book Assessing Nanoparticle Risks to Human Health by
Cover of the book Denim by
Cover of the book Solutions for Biot's Poroelastic Theory in Key Engineering Fields by
Cover of the book Understanding AC Circuits by
Cover of the book 4M 2006 - Second International Conference on Multi-Material Micro Manufacture by
Cover of the book Smart Textiles for In Situ Monitoring of Composites by
Cover of the book Complementarity and Variational Inequalities in Electronics by
Cover of the book Handbook of Asian Finance by
Cover of the book PEM Water Electrolysis by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy